GH successful treatment in a female with a de novo 46,XX,add(X)(p36),t(X;Y)(p36.3;p11.2), growth impairment and SHOX-haploinsufficiency
- PMID: 31412912
- PMCID: PMC6692937
- DOI: 10.1186/s13052-019-0694-y
GH successful treatment in a female with a de novo 46,XX,add(X)(p36),t(X;Y)(p36.3;p11.2), growth impairment and SHOX-haploinsufficiency
Abstract
Children with chromosome translocations, concerning X chromosome, have a genetic pattern different from Turner syndrome; however, when a translocation involves the of part of X chromosome including short stature homeobox-containing Sex-determining Region Y gene, growth may be severely compromised.We describe the clinical case of a 2.2-year-old-female, arrived at our paediatric unit for a decrease of height velocity. The karyotype was 46,XX,add(X)(p36.3). Array comparative genomic hybridization showed a fragment of Y chromosome, extended from 8.803.981 (Yp11.2) to 28.767.604 (Yq11.23). The final karyotype was 46,XX,add(X)(p36),t(X;Y)(p36.3;p11.2). Fluorescence in situ Hybridization analysis using Sex-determining Region Y probe revealed no signal on the derivative Y chromosome.At the admittance, height was 84.5 cm (- 1.24 SDS); SPAN was 79 cm; sitting height: 72.4 cm; weight was 17.5 kg. Bone age was 1.2 years. Multiplex Ligation Probe Amplification showed a heterozygous deletion of the Short Stature Homeobox-containing gene and of the pseudoautosomal region-1. This result correlated with Leri-Weill Syndrome. She started Growth Hormone treatment, with a good response.The case described shows a rare translocation, involving the X chromosome and including SHOX gene and the pseudoautosomal region-1. At our knowledge, this is the first case of a patient with a karyotype 46,XX,add(X)(p36),t(X;Y)(p36.3;p11.2) and Short Stature Homeobox-containing gene haploinsufficiency, successfully treated with Growth Hormone.
Keywords: Chromosome translocation; Growth hormone; SHOX haploinsufficiency; Treatment adherence.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Similar articles
-
Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX.Endocr J. 2001 Jun;48(3):317-22. doi: 10.1507/endocrj.48.317. Endocr J. 2001. PMID: 11523902
-
Prevalence of SHOX haploinsufficiency among short statured children.Pediatr Res. 2017 Feb;81(2):335-341. doi: 10.1038/pr.2016.233. Epub 2016 Nov 4. Pediatr Res. 2017. PMID: 27814343
-
Translocation (Y;22) resulting in the loss of SHOX and isolated short stature.Am J Med Genet A. 2004 Mar 1;125A(2):186-90. doi: 10.1002/ajmg.a.20346. Am J Med Genet A. 2004. PMID: 14981722
-
[Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment].Arq Bras Endocrinol Metabol. 2008 Jul;52(5):765-73. doi: 10.1590/s0004-27302008000500008. Arq Bras Endocrinol Metabol. 2008. PMID: 18797583 Review. Portuguese.
-
SHOX: pseudoautosomal homeobox containing gene for short stature and dyschondrosteosis.Growth Horm IGF Res. 1999 Jun;9 Suppl B:53-7; discussion 57-8. doi: 10.1016/s1096-6374(99)80082-3. Growth Horm IGF Res. 1999. PMID: 10549307 Review.
Cited by
-
Efficacy and Safety of Growth Hormone (GH) Therapy in Patients with SHOX Gene Variants.Children (Basel). 2025 Mar 4;12(3):325. doi: 10.3390/children12030325. Children (Basel). 2025. PMID: 40150607 Free PMC article. Review.
References
-
- Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G, et al. GH treatment to final height produces similar height gains in patients with SHOX deficiency and turner syndrome: results of a multicenter trial. J Clin Endocrinol Metab. 2013;98(8):E1383–E1392. doi: 10.1210/jc.2013-1222. - DOI - PubMed
-
- Iughetti L, Vannelli S, Street ME, Pirazzoli P, Bertelloni S, Radetti G, et al. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy. Horm Res Paediatr. 2012;78(5–6):279–287. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials